Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CMA1 | P23946 | 19/20 | 0.77 |
| ▸ | F2 | P00734 | 2/20 | 0.63 |
| ▸ | CTSG | P08311 | 2/20 | 0.63 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.63 |
| ▸ | ELANE | P08246 | 1/20 | 0.63 |
| ▸ | CTRC | Q99895 | 1/20 | 0.62 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6479887 | 0.94 | CMA1 (0.71) | CMA1F2CTSGPRSS1ELANE | |
| SCHEMBL6438726 | 0.91 | CMA1 (0.82) | CMA1F2CTSGPRSS1ELANE | |
| SCHEMBL6469309 | 0.91 | CMA1 (0.68) | CMA1F2CTSGPRSS1ELANE | |
| SCHEMBL5620407 | 0.88 | CMA1 (1.00) | CMA1F2CTSGPRSS1ELANE | |
| SCHEMBL6453073 | 0.82 | CMA1 (1.00) | CMA1F2CTSGPRSS1ELANE | |
| SCHEMBL6456455 | 0.80 | CMA1 (0.68) | CMA1F2CTSGPRSS1ELANE | |
| SCHEMBL6459484 | 0.80 | CMA1 (0.88) | CMA1F2CTSGPRSS1ELANE | |
| SCHEMBL6456450 | 0.80 | CMA1 (0.85) | CMA1F2CTSGPRSS1ELANE | |
| SCHEMBL6453077 | 0.74 | CMA1 (0.61) | CMA1F2CTSGPRSS1ELANE | |
| Flomoxef SCHEMBL14423926 | 0.74 | PTGS1 (0.57) | CMA1PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005074932-A1 | THE USE OF (S) - PANTOPRAZOLE MAGNESIUM FOR THE TREATMENT OF AIRWAY DISORDERS | ALTANA PHARMA AG (DE) | 2005-08-18 | — | — | WO | disclosed |
| US-20050165041-A1 | Combination for the treatment of airway disorders | ALTANA PHARMA AG (DE) | 2005-07-28 | — | — | US | disclosed |